ULTRALIFE CORP — Director's Dealing 2021

Dec 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2021-12-17

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-17	Common Stock; $.10 par value	M	6583	$3.7876	Acquired	316509	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-17	Stock Options	$3.7876	M	20000	Disposed	2022-03-05	Common Stock (20000)	Direct

Footnotes

F1: Represents shares of common stock acquired by the Reporting Person upon exercise of options for 20,000 shares of common stock of the Company, net of 13,417 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long-Term Incentive Plan in payment of the exercise price for the options.

F2: Represents exercise of options for 20,000 shares of common stock of the Company otherwise expiring on 3/5/2022.